ALX Oncology Holdings Inc (ALXO)
10.61
-0.04
(-0.38%)
USD |
NASDAQ |
May 31, 16:00
10.60
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2020 | 0.527M |
| March 31, 2020 | 0.655M |
| December 31, 2019 | 1.213M |
| Date | Value |
|---|---|
| September 30, 2019 | 1.256M |
| June 30, 2019 | 1.295M |
| March 31, 2019 | 1.032M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.527M
Minimum
Jun 2020
1.295M
Maximum
Jun 2019
0.9892M
Average
1.213M
Median
Dec 2019
Revenue (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 11.86B |
| Annovis Bio Inc | -- |
| Verastem Inc | -- |
| Nurix Therapeutics Inc | 16.58M |
| Exelixis Inc | 425.23M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.58M |
| Total Expenses (Quarterly) | 37.76M |
| EPS Diluted (Quarterly) | -0.71 |
| Enterprise Value | 405.05M |
| Earnings Yield | -34.97% |
| Normalized Earnings Yield | -9.915 |